These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 33315784

  • 1. Women Are Less Likely to Be Tested for HIV or Offered Preexposure Prophylaxis at the Time of Sexually Transmitted Infection Diagnosis.
    Yumori C, Zucker J, Theodore D, Chang M, Carnevale C, Slowikowski J, LaSota E, Olender S, Gordon P, Cohall A, Sobieszczyk ME.
    Sex Transm Dis; 2021 Jan; 48(1):32-36. PubMed ID: 33315784
    [Abstract] [Full Text] [Related]

  • 2. Rates of New Human Immunodeficiency Virus (HIV) Diagnoses After Reported Sexually Transmitted Infection in Women in Louisiana, 2000-2015: Implications for HIV Prevention.
    Newman DR, Rahman MM, Brantley A, Peterman TA.
    Clin Infect Dis; 2020 Mar 03; 70(6):1115-1120. PubMed ID: 30976788
    [Abstract] [Full Text] [Related]

  • 3. Sexually Transmitted Infection Screening Among Gay, Bisexual, and Other Men Who Have Sex With Men Prescribed Pre-exposure Prophylaxis in Baltimore City, Maryland.
    Schumacher C, Wu L, Chandran A, Fields E, Price A, Greenbaum A, Jennings JM, IMPACT Partner Collaborative.
    Clin Infect Dis; 2020 Dec 17; 71(10):2637-2644. PubMed ID: 31761944
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis.
    Tang EC, Vittinghoff E, Philip SS, Doblecki-Lewis S, Bacon O, Chege W, Coleman ME, Elion R, Buchbinder S, Kolber MA, Liu AY, Cohen SE.
    AIDS; 2020 Jul 01; 34(8):1181-1186. PubMed ID: 32205724
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review.
    Ong JJ, Fu H, Baggaley RC, Wi TE, Tucker JD, Smith MK, Rafael S, Falconer J, Terris-Prestholt F, Mameletzis I, Mayaud P.
    J Int AIDS Soc; 2021 Feb 01; 24(2):e25673. PubMed ID: 33605081
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inequities Along the Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Services Continuum for Black Women in the United States, 2015-2020.
    Townes A, Tanner MR, Yu L, Johnson WD, Zhu W, Iqbal K, Dominguez KL, Henny KD, Drezner K, Schumacher C, Bickham J, Elopre L, Edelstein ZR, Hoover KW, Targeted Highly Effective Interventions to Reverse the HIV Epidemic (THRIVE) Project Team*.
    Obstet Gynecol; 2024 Feb 01; 143(2):294-301. PubMed ID: 37963384
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E, Coyer L, Achterbergh RCA, Matser A, Schim van der Loeff MF, Boyd A, van Duijnhoven YTHP, Bruisten S, Oostvogel P, Davidovich U, Hogewoning A, Prins M, de Vries HJC, Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam (H-TEAM) Initiative.
    Lancet HIV; 2019 Jul 01; 6(7):e447-e455. PubMed ID: 31178284
    [Abstract] [Full Text] [Related]

  • 17. STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany.
    Jansen K, Steffen G, Potthoff A, Schuppe AK, Beer D, Jessen H, Scholten S, Spornraft-Ragaller P, Bremer V, Tiemann C, MSM Screening Study group.
    BMC Infect Dis; 2020 Feb 07; 20(1):110. PubMed ID: 32033533
    [Abstract] [Full Text] [Related]

  • 18. HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019.
    Streeck H, Jansen K, Crowell TA, Esber A, Jessen HK, Cordes C, Scholten S, Schneeweiss S, Brockmeyer N, Spinner CD, Bickel M, Esser S, Hartikainen J, Stoehr A, Lehmann C, Marcus U, Vehreschild JJ, Knorr A, Brillen AL, Tiemann C, Robb ML, Michael NL.
    Euro Surveill; 2022 Apr 07; 27(14):. PubMed ID: 35393933
    [Abstract] [Full Text] [Related]

  • 19. Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men.
    McManus H, Grulich AE, Amin J, Selvey C, Vickers T, Bavinton B, Zablotska I, Vaccher S, Jin F, Holden J, Price K, Yeung B, Cabrera Quichua G, Ogilvie E, McNulty A, Smith D, Guy R.
    JAMA Netw Open; 2020 Dec 01; 3(12):e2030806. PubMed ID: 33355675
    [Abstract] [Full Text] [Related]

  • 20. Factors Associated With Willingness to Use Daily Antibiotics as Sexually Transmitted Infection Prophylaxis Among HIV Preexposure Prophylaxis-Experienced Gay and Bisexual Men in Australia.
    Arapali T, Grulich AE, Heywood AE, Chan C, Fraser D, Zablotska IB, Holt M, Vaccher SJ, Bavinton BR.
    Sex Transm Dis; 2023 Mar 01; 50(3):144-149. PubMed ID: 36730780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.